Serum Hepatocyte Growth Factor (HGF) estimation and its correlation  study with Hormonal Receptor Status (ER, PR, and HER2/neu) in  Carcinoma Breast

Dr Chaithra V., Dr Rekha T S, Dr Rashmi N

Serum Hepatocyte Growth Factor (HGF) estimation and its correlation study with Hormonal Receptor Status (ER, PR, and HER2/neu) in Carcinoma Breast

Authors

Dr Chaithra V., Dr Rekha T S, Dr Rashmi N

Keywords:

Breast carcinoma, Hepatocyte Growth Factor, HGF, ER, PR, HER2/neu, Triple-negative breast cancer, Biomarker.

Abstract

Background: Hepatocyte Growth Factor(HGF) and its receptor c-MET are involved in breast cancer progression, angiogenesis,invasion, and metastasis. Serum HGF hasemerged as a potential biomarker for tumoraggressiveness. Aim: To evaluate serumHGF levels in breast carcinoma patientsand correlate them with ER, PR, andHER2/neu receptor status.

References

1. Mallath MK, Taylor DG, Badwe RA, Rath GK, Shanta V, Pramesh CS et al. The growing burden of cancer in India: epidemiology and social context. TheLancet Oncology. 2014;15(6):e205-12.

Downloads

Published

2026-07-12

How to Cite

Dr Chaithra V., Dr Rekha T S, Dr Rashmi N. (2026). Serum Hepatocyte Growth Factor (HGF) estimation and its correlation study with Hormonal Receptor Status (ER, PR, and HER2/neu) in Carcinoma Breast . International Journal of Pharmacy Research & Technology (IJPRT), 16(2), 2543–2549. Retrieved from https://ijprt.org/index.php/pub/article/view/2721